Cargando…

Inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements

Peptide 204–212 of lipocortin (LC) 5 inhibited porcine pancreatic phospholipase A(2) (PLA(2)) induced rat stomach strip contractions and ADP induced rabbit platelet aggregation in a concentration dependent manner (IC(30) of 10 μM and 400 μM, respectively). The first two amino acids are not necessary...

Descripción completa

Detalles Bibliográficos
Autores principales: Mugridge, K. G., Becherucci, C., Parente, L., Perretti, M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1993
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365395/
https://www.ncbi.nlm.nih.gov/pubmed/18475510
http://dx.doi.org/10.1155/S0962935193000146
_version_ 1782154157985103872
author Mugridge, K. G.
Becherucci, C.
Parente, L.
Perretti, M.
author_facet Mugridge, K. G.
Becherucci, C.
Parente, L.
Perretti, M.
author_sort Mugridge, K. G.
collection PubMed
description Peptide 204–212 of lipocortin (LC) 5 inhibited porcine pancreatic phospholipase A(2) (PLA(2)) induced rat stomach strip contractions and ADP induced rabbit platelet aggregation in a concentration dependent manner (IC(30) of 10 μM and 400 μM, respectively). The first two amino acids are not necessary since the eptapeptide 206–212 was equipotent in both assays (IC(30) of 12.5 μM and 420 μM). Of the two pentapeptides 204–208 and 208–212 only the latter showed inhibitory activity in both models although the potency was much reduced (IC(30) of 170 μM and 630 μM) compared with that of the parent nonapeptide. Comparison of peptide 204–212 effects with those of its analogues on LC1 and LC2 indicate that lysine 208 and aspartic acid 211 are essential in order to maintain a fully active nonapeptide.
format Text
id pubmed-2365395
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23653952008-05-12 Inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements Mugridge, K. G. Becherucci, C. Parente, L. Perretti, M. Mediators Inflamm Research Article Peptide 204–212 of lipocortin (LC) 5 inhibited porcine pancreatic phospholipase A(2) (PLA(2)) induced rat stomach strip contractions and ADP induced rabbit platelet aggregation in a concentration dependent manner (IC(30) of 10 μM and 400 μM, respectively). The first two amino acids are not necessary since the eptapeptide 206–212 was equipotent in both assays (IC(30) of 12.5 μM and 420 μM). Of the two pentapeptides 204–208 and 208–212 only the latter showed inhibitory activity in both models although the potency was much reduced (IC(30) of 170 μM and 630 μM) compared with that of the parent nonapeptide. Comparison of peptide 204–212 effects with those of its analogues on LC1 and LC2 indicate that lysine 208 and aspartic acid 211 are essential in order to maintain a fully active nonapeptide. Hindawi Publishing Corporation 1993 /pmc/articles/PMC2365395/ /pubmed/18475510 http://dx.doi.org/10.1155/S0962935193000146 Text en Copyright © 1993 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mugridge, K. G.
Becherucci, C.
Parente, L.
Perretti, M.
Inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements
title Inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements
title_full Inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements
title_fullStr Inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements
title_full_unstemmed Inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements
title_short Inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements
title_sort inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365395/
https://www.ncbi.nlm.nih.gov/pubmed/18475510
http://dx.doi.org/10.1155/S0962935193000146
work_keys_str_mv AT mugridgekg inhibitionofsmoothmusclecontractionandplateletaggregationbypeptide204212oflipocortin5anattempttodefinesomestructurerequirements
AT becheruccic inhibitionofsmoothmusclecontractionandplateletaggregationbypeptide204212oflipocortin5anattempttodefinesomestructurerequirements
AT parentel inhibitionofsmoothmusclecontractionandplateletaggregationbypeptide204212oflipocortin5anattempttodefinesomestructurerequirements
AT perrettim inhibitionofsmoothmusclecontractionandplateletaggregationbypeptide204212oflipocortin5anattempttodefinesomestructurerequirements